Intellia Therapeutics' Series B Round

Intellia Therapeutics raised a round of funding on September 01, 2015.

Intellia Therapeutics is a gene-editing company focused on the development of proprietary products utilizing the recently discovered CRISPR/Cas9 technology. Intellia intends to advance its pipeline an…

Articles about Intellia Therapeutics' Series B Round: